T1dm - Type 1 Diabetes Mellitus Clinical Trials
2 recruiting trials for T1dm - Type 1 Diabetes Mellitus. Eligibility criteria explained in plain English.
TrialFinderData lists 2 T1dm - Type 1 Diabetes Mellitus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Early Phase 1 is the largest group at 50% (1 studies); the largest phase groups are Early Phase 1: 1, Phase 1 / Phase 2: 1.
Research is led by Shanghai Zhongshan Hospital (1), Otsuka Pharmaceutical Factory, Inc. (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Allogeneic CD7-Targeted CAR-T Cell Injection (biological, 1 trial), followed by OPF-310.
Track T1dm - Type 1 Diabetes Mellitus trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
Type 1 diabetes mellitus (T1DM) is a T cell-mediated autoimmune disease characterized by autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency...
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes...
This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for T1dm - Type 1 Diabetes Mellitus, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for T1dm - Type 1 Diabetes Mellitus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for T1dm - Type 1 Diabetes Mellitus, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.